Kemic

Dexketoprofen, the active ingredient in Kemic, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It is indicated for the relief of mild to moderate pain, including musculoskeletal, post‑operative and dental discomfort, in adult patients.

GNH USA supplies Kemic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dexketoprofen acts as an NSAID to reduce pain and inflammation in several clinical settings. - Mild to moderate pain: provides analgesia for everyday aches and short‑term discomfort. - Musculoskeletal pain: alleviates pain associated with strains, sprains and inflammatory joint conditions. - Post‑operative pain: helps control pain after surgical procedures. - Dental pain: reduces pain and swelling following dental interventions.

Dexketoprofen may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dyspepsia or stomach discomfort. - Nausea or vomiting. - Headache. - Dizziness. - Diarrhoea. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe allergic reactions such as angioedema or anaphylaxis. - Hepatic dysfunction. - Renal impairment or acute kidney injury. - Cardiovascular events like myocardial infarction or stroke. - Blood dyscrasias including thrombocytopenia.

When using Dexketoprofen, consider the following safety measures. - Gastrointestinal risk: avoid use in patients with active ulcers or a history of GI bleeding. - Cardiovascular caution: use cautiously in individuals with established heart disease or risk factors. - Renal monitoring: assess kidney function in patients with pre‑existing renal impairment. - Drug interactions: review concomitant medications, especially other NSAIDs or anticoagulants. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Dexketoprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other NSAIDs or aspirin: increased risk of gastrointestinal bleeding. - Anticoagulants (e.g., warfarin): potentiation of anticoagulant effect leading to hemorrhage. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive efficacy. - Diuretics: risk of renal function decline. - Lithium: NSAIDs may raise lithium serum levels. - Methotrexate: reduced clearance may increase toxicity. - Corticosteroids: additive gastrointestinal ulcer risk.